Popkov M, Lussier I, Medvedkine V, Estève P O, Alakhov V, Mandeville R
Institute Armand-Frappier, University of Quebec, Laval, Canada.
Eur J Biochem. 1998 Jan 15;251(1-2):155-63. doi: 10.1046/j.1432-1327.1998.2510155.x.
A phage display library of random decapeptides was used to generate peptide ligands that can bind multidrug-resistance (MDR) drugs mimicking, in this respect, the drug-binding activity of P-glycoprotein. Seven peptide sequences were identified that specifically bound doxorubicin. Five of these sequences expressed the core consensus motif WXXW. The displacement assay showed that the phages expressing these peptides bound MDR type drugs (vinblastine, doxorubicin, verapamil, and genistein) with the same selectivity as P-glycoprotein and did not interact with non-MDR type drugs, such as arabinosylcytosine (Ara-C) and melphalan. One of the selected peptides that showed a highest capacity for the binding (VCDWWGWGIC) was synthesized and displayed competition with the phage for doxorubicin binding. The structure modeling suggested that all the selected sequences contained a hydrophobic envelope in which MDR drugs could be docked with substantial energy minimization. Western blot analysis showed that monospecific antibody obtained against the phage expressing VCDWWGWGIC peptide could specifically recognize P-glycoprotein in the membrane fraction of MDR phenotype MCF-7ADR cells. The MDR drug-binding sequences generated during this work could provide an important tool for design and screening of new chemotherapeutic agents.
使用随机十肽噬菌体展示文库来生成能够结合多药耐药(MDR)药物的肽配体,在这方面模拟P-糖蛋白的药物结合活性。鉴定出七个能特异性结合阿霉素的肽序列。其中五个序列表达核心共有基序WXXW。置换试验表明,表达这些肽的噬菌体以与P-糖蛋白相同的选择性结合MDR型药物(长春碱、阿霉素、维拉帕米和染料木黄酮),并且不与非MDR型药物相互作用,如阿糖胞苷(Ara-C)和美法仑。合成了一种结合能力最强的所选肽(VCDWWGWGIC),并显示其与噬菌体竞争阿霉素结合。结构建模表明,所有所选序列都包含一个疏水包膜,MDR药物可以在其中以显著的能量最小化方式对接。蛋白质印迹分析表明,针对表达VCDWWGWGIC肽的噬菌体获得的单特异性抗体可以特异性识别MDR表型MCF-7ADR细胞的膜部分中的P-糖蛋白。在这项工作中产生的MDR药物结合序列可为新型化疗药物的设计和筛选提供重要工具。